Calando Pharmaceuticals
About:
Calando Pharmaceuticals focuses on creating targeted therapeutics for the development of nanoparticle drug formulations.
Website: http://www.insertt.com
Top Investors: Arrowhead Pharmaceuticals
Description:
Calando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations. Calando’s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.
$11M
Pasadena, California, United States
2000-01-01
Mark E. Davis, Robert Grubbs
1-10
2011-01-18
Private
© 2025 bioDAO.ai